Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals

INTRODUCTION: Fixed-dose combinations (FDC) contain two or more active ingredients. The effective patent and exclusivity life of FDC compared to single active ingredient has not been assessed. OBJECTIVES: Trends in FDA approved FDC in the period 1980–2012 and time lag between approval of FDC and sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Jing, Rodriguez-Monguio, Rosa, Seoane-Vazquez, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607470/
https://www.ncbi.nlm.nih.gov/pubmed/26469277
http://dx.doi.org/10.1371/journal.pone.0140708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607470/
https://www.ncbi.nlm.nih.gov/pubmed/26469277
http://dx.doi.org/10.1371/journal.pone.0140708

Ejemplares similares